However, before validation of the role of A1CF in breast cancer, more studies are required to address the prevalence of A1CF (-8aa) in breast cancer and whether blocking A1CF (-8aa) or the corresponding alternative splice event can help cancer therapy. Here, A1CF is linked to cancer.